• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一氧化氮途径在阿尔茨海默病淀粉样蛋白升高后的突触功能障碍中的作用。

Involvement of the nitric oxide pathway in synaptic dysfunction following amyloid elevation in Alzheimer's disease.

作者信息

Puzzo Daniela, Palmeri Agostino, Arancio Ottavio

机构信息

Department of Pathology, Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University, New York, NY, USA.

出版信息

Rev Neurosci. 2006;17(5):497-523. doi: 10.1515/revneuro.2006.17.5.497.

DOI:10.1515/revneuro.2006.17.5.497
PMID:17180876
Abstract

Amyloid-beta (Abeta), a peptide thought to play a crucial role in Alzheimer's disease (AD), has attracted scientific interest with the aim of characterizing the mechanisms by which it is involved in AD pathogenesis. Abeta has been found to markedly impair hippocampal long-term potentiation (LTP), a widely studied cellular model of synaptic plasticity that is thought to underlie learning and memory. The overall purpose of this review is to define the role of the nitric oxide (NO)/cGMP/cAMP-regulatory element binding (CREB) pathway in beta-amyloid-induced changes of basal neurotransmission and synaptic plasticity in the hippocampus, a structure within the temporal lobe of the brain critical for memory storage.

摘要

β-淀粉样蛋白(Aβ)是一种被认为在阿尔茨海默病(AD)中起关键作用的肽,为了阐明其参与AD发病机制的机制,它已引起了科学界的关注。人们发现Aβ会显著损害海马体长期增强效应(LTP),LTP是一种被广泛研究的突触可塑性细胞模型,被认为是学习和记忆的基础。本综述的总体目的是确定一氧化氮(NO)/环鸟苷酸(cGMP)/环磷酸腺苷(cAMP)反应元件结合蛋白(CREB)信号通路在β-淀粉样蛋白诱导的海马体基础神经传递和突触可塑性变化中的作用,海马体是大脑颞叶内对记忆存储至关重要的结构。

相似文献

1
Involvement of the nitric oxide pathway in synaptic dysfunction following amyloid elevation in Alzheimer's disease.一氧化氮途径在阿尔茨海默病淀粉样蛋白升高后的突触功能障碍中的作用。
Rev Neurosci. 2006;17(5):497-523. doi: 10.1515/revneuro.2006.17.5.497.
2
Amyloid-beta peptide inhibits activation of the nitric oxide/cGMP/cAMP-responsive element-binding protein pathway during hippocampal synaptic plasticity.淀粉样β肽在海马突触可塑性过程中抑制一氧化氮/cGMP/环磷酸腺苷反应元件结合蛋白信号通路的激活。
J Neurosci. 2005 Jul 20;25(29):6887-97. doi: 10.1523/JNEUROSCI.5291-04.2005.
3
Synaptic and memory dysfunction induced by tau oligomers is rescued by up-regulation of the nitric oxide cascade.tau 寡聚物诱导的突触和记忆功能障碍可通过一氧化氮级联的上调来挽救。
Mol Neurodegener. 2019 Jun 27;14(1):26. doi: 10.1186/s13024-019-0326-4.
4
Amyloid-β Peptide Is Needed for cGMP-Induced Long-Term Potentiation and Memory.环磷酸鸟苷诱导的长时程增强和记忆需要β淀粉样肽。
J Neurosci. 2017 Jul 19;37(29):6926-6937. doi: 10.1523/JNEUROSCI.3607-16.2017. Epub 2017 Jun 16.
5
Stimulation of the Hippocampal POMC/MC4R Circuit Alleviates Synaptic Plasticity Impairment in an Alzheimer's Disease Model.刺激海马POMC/MC4R回路可减轻阿尔茨海默病模型中的突触可塑性损伤。
Cell Rep. 2016 Nov 8;17(7):1819-1831. doi: 10.1016/j.celrep.2016.10.043.
6
Human Brain-Derived Aβ Oligomers Bind to Synapses and Disrupt Synaptic Activity in a Manner That Requires APP.人脑源性β淀粉样蛋白寡聚体以一种需要淀粉样前体蛋白(APP)的方式与突触结合并破坏突触活动。
J Neurosci. 2017 Dec 6;37(49):11947-11966. doi: 10.1523/JNEUROSCI.2009-17.2017. Epub 2017 Nov 3.
7
[Effects of amyloid β-protein on hippocampal long-term potentiation].[β-淀粉样蛋白对海马体长期增强效应的影响]
Sheng Li Xue Bao. 2010 Dec 25;62(6):479-88.
8
Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers.细胞朊蛋白介导β-淀粉样寡聚体对突触可塑性的损害。
Nature. 2009 Feb 26;457(7233):1128-32. doi: 10.1038/nature07761.
9
Impact of blunting astrocyte activity on hippocampal synaptic plasticity in a mouse model of early Alzheimer's disease based on amyloid-β peptide exposure.在基于淀粉样β肽暴露的早期阿尔茨海默病小鼠模型中,抑制星形胶质细胞活性对海马突触可塑性的影响。
J Neurochem. 2022 Mar;160(5):556-567. doi: 10.1111/jnc.15575. Epub 2022 Feb 12.
10
Decoding the synaptic dysfunction of bioactive human AD brain soluble Aβ to inspire novel therapeutic avenues for Alzheimer's disease.解析具有生物活性的人源 AD 脑可溶性 Aβ 的突触功能障碍,为阿尔茨海默病提供新的治疗途径。
Acta Neuropathol Commun. 2018 Nov 8;6(1):121. doi: 10.1186/s40478-018-0626-x.

引用本文的文献

1
Phosphodiesterase (PDE) III inhibitor, Cilostazol, improved memory impairment in aluminum chloride-treated rats: modulation of cAMP/CREB pathway.磷酸二酯酶 (PDE) III 抑制剂西洛他唑改善了氯化铝处理大鼠的记忆障碍:环磷酸腺苷 (cAMP)/cAMP 反应元件结合蛋白 (CREB) 通路的调节。
Inflammopharmacology. 2022 Dec;30(6):2477-2488. doi: 10.1007/s10787-022-01010-1. Epub 2022 Jun 21.
2
Structure-based discovery and bio-evaluation of a cyclopenta[4,5]thieno[2,3-]pyrimidin-4-one as a phosphodiesterase 10A inhibitor.基于结构的环戊并[4,5]噻吩并[2,3 - ]嘧啶 - 4 - 酮作为磷酸二酯酶10A抑制剂的发现及生物学评价
RSC Adv. 2022 Jan 11;12(3):1576-1591. doi: 10.1039/d1ra07649c. eCollection 2022 Jan 5.
3
var. Improves Cognitive Impairment under Amyloid Beta-Induced Alzheimer's Disease Model.
改善淀粉样β诱导的阿尔茨海默病模型下的认知障碍。
Biomed Res Int. 2022 Jan 7;2022:4513998. doi: 10.1155/2022/4513998. eCollection 2022.
4
Alteration in Cngb1 Expression upon Maternal Immune Activation in a Mouse Model and Its Possible Association with Schizophrenia Susceptibility.小鼠模型中母体免疫激活后Cngb1表达的改变及其与精神分裂症易感性的可能关联。
Clin Psychopharmacol Neurosci. 2021 Nov 30;19(4):618-627. doi: 10.9758/cpn.2021.19.4.618.
5
Nitric oxide and the brain. Part 1: Mechanisms of regulation, transport and effects on the developing brain.一氧化氮与大脑。第1部分:调节、转运机制及其对发育中大脑的影响。
Pediatr Res. 2021 Mar;89(4):738-745. doi: 10.1038/s41390-020-1017-0. Epub 2020 Jun 20.
6
Furoxans (Oxadiazole-4 N-oxides) with Attenuated Reactivity are Neuroprotective, Cross the Blood Brain Barrier, and Improve Passive Avoidance Memory.具有低反应性的呋咱类化合物(氧化呋咱-4-N-氧化物)具有神经保护作用,可穿透血脑屏障,并改善被动回避记忆。
J Med Chem. 2018 May 24;61(10):4593-4607. doi: 10.1021/acs.jmedchem.8b00389. Epub 2018 May 7.
7
Regucalcin confers resistance to amyloid-β toxicity in neuronally differentiated PC12 cells.调钙素赋予神经分化的PC12细胞对β-淀粉样蛋白毒性的抗性。
FEBS Open Bio. 2018 Jan 20;8(3):349-360. doi: 10.1002/2211-5463.12374. eCollection 2018 Mar.
8
Identification of a Novel 1,2,3,4-Tetrahydrobenzo[b][1,6]naphthyridine Analogue as a Potent Phosphodiesterase 5 Inhibitor with Improved Aqueous Solubility for the Treatment of Alzheimer's Disease.鉴定一种新型的1,2,3,4-四氢苯并[b][1,6]萘啶类似物作为一种有效的磷酸二酯酶5抑制剂,其具有改善的水溶性,用于治疗阿尔茨海默病。
J Med Chem. 2017 Nov 9;60(21):8858-8875. doi: 10.1021/acs.jmedchem.7b00979. Epub 2017 Oct 23.
9
Soluble beta amyloid evokes alteration in brain norepinephrine levels: role of nitric oxide and interleukin-1.可溶性β淀粉样蛋白引起脑去甲肾上腺素水平改变:一氧化氮和白细胞介素-1的作用。
Front Neurosci. 2015 Nov 5;9:428. doi: 10.3389/fnins.2015.00428. eCollection 2015.
10
Re-engineering a neuroprotective, clinical drug as a procognitive agent with high in vivo potency and with GABAA potentiating activity for use in dementia.将一种具有神经保护作用的临床药物重新设计为一种具有高体内效力且具有GABAA增强活性的促认知药物,用于治疗痴呆症。
BMC Neurosci. 2015 Oct 19;16:67. doi: 10.1186/s12868-015-0208-9.